Abzena
PrivateLast Round
Private Equity
Mar 31, 2022
Est. Valuation
$44.4M
Total Funding Raised
$126.9M
Momentum Score
25 /100
Company Overview
Abzena is a biotechnology company that provides integrated discovery, development, and manufacturing services for biologics and antibody-drug conjugates (ADCs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abzena Comps
Public and private peers based on sector, stage, and business model.
Abzena Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Mar 31, 2022 | ||||
| Growth Equity | Jul 28, 2020 | ||||
| Take Private | Aug 17, 2018 | ||||
| Follow-on Offering | Apr 5, 2017 | ||||
| Private Placement | Nov 24, 2015 | ||||
IPO Announced | Jul 10, 2014 |
Key People
Founding team and executive leadership
Abzena Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invesco Ltd. | Follow-on Offering |
| Biospring Partners | Private Equity, Growth Equity |
| Advantage Enterprise & Innovation Fund | Series A |
| Cavendish | IPO |
| Woodford Investment Management | IPO, Follow-on Offering |
| Imperial Innovations | IPO, Series A |
| Invesco Perpetual | Series A, IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 36% MoM, reaching 15.6K.
- Oct 28, 2024
Monthly visitors increased 65% MoM.
Abzena Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abzena's valuation, stock price, and market status.
